EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Transgender Women With Suppressed Testosterone Display Lower Burden of Coronary Disease Than Matched Cisgender Men

Jordan E Lake iD, Han Feng iD, Ana N Hyatt iD, Hongyu Miao, Paula Debroy iD, Nicholas Funderburg iD, Kate Ailstock, Adrian Dobs iD, Sabina Haberlen iD, Jared W Magnani iD, Joseph B Margolick, Kate McGowan iD und 6 weitere

Journal of the Endocrine Society · 01.07.2024 · 8 (8)

DOI: 10.1210/jendso/bvae120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 27.06.2024. Verfasst von Jordan E Lake und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, UTHealth Houston, Houston, TX 77030, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Cardiovascular disease (CVD) in transgender women (TW) may be affected by gender-affirming hormone therapy (GAHT) and HIV, but few data compare TW on contemporary GAHT to well-matched controls.

Objective

We compared CVD burden and biomarker profiles between TW and matched cisgender men (CM).

Methods

Adult TW on GAHT (n = 29) were recruited for a cross-sectional study (2018-2020). CM (n = 48) from the former Multicenter AIDS Cohort Study were matched 2:1 to TW on HIV serostatus, age ±5 years, race/ethnicity, BMI category and antiretroviral therapy (ART) type. Cardiac parameters were measured by CT and coronary atherosclerosis by coronary CT angiography; sex hormone and biomarker concentrations were measured centrally from stored samples.

Results

Overall, median age was 53 years and BMI 29 kg/m2; 69% were non-white. All participants with HIV (71%) had viral suppression on ART. Only 31% of TW had testosterone suppression (<50 ng/dL, TW-S). Traditional CVD risk factors were similar between groups, except that TW-S had higher BMI than TW with non-suppressed testosterone (TW-T). TW-S had no evidence of non-calcified coronary plaque or advanced coronary stenosis, whereas TW-T and CM had similar burden. TW had lower prevalence of any coronary plaque, calcified plaque and mixed plaque than CM, regardless of testosterone concentrations and HIV serostatus. Estradiol but not testosterone concentrations moderately and negatively correlated with the presence of coronary plaque and stenosis. Small sample size limited statistical power.

Conclusion

Older TW with suppressed total testosterone on GAHT had no CT evidence of non-calcified coronary plaque or advanced coronary stenosis. Longitudinal studies to understand relationships between GAHT and CVD risk in TW are needed.

Schlagwörter

Stichwörter der Autor:innen

HIVcoronary diseasegender-affirming hormone therapytransgender women

Autor:innen und Institutionen

  • Department of Medicine, UTHealth Houston, Houston, TX 77030, USA.
  • Tulane Research and Innovation for Arrhythmia Discoveries-TRIAD Center, Tulane University School of Medicine, New Orleans, LA 70112, USA.
  • Department of Statistics and College of Nursing, Florida State University, Tallahassee, FL 32306, USA.
  • Division of Medical Laboratory Science, The Ohio State University, Columbus, OH 43210, USA.
  • Department of Medicine, Johns Hopkins University, Baltimore, MD 21218, USA.
  • Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.

ORCID-Profile: Jordan E Lake, Han Feng, Ana N Hyatt, Paula Debroy, Nicholas Funderburg, Adrian Dobs, Sabina Haberlen, Jared W Magnani, Kate McGowan, Frank J Palella, Mallory D Witt, Shalender Bhasin, Matthew J Budoff, Wendy S Post

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NCRR NIH HHS
  • NIH
  • National Center for Advancing Translational Sciences
  • National Institutes of Health Roadmap for Medical Research
  • Developmental Center for AIDS Research
  • Multicenter AIDS Cohort Study

Zitieren

APA

Lake, J. E., Feng, H., Hyatt, A. N., Miao, H., Debroy, P., Funderburg, N., Ailstock, K., Dobs, A., Haberlen, S., Magnani, J. W., Margolick, J. B., McGowan, K., Palella, F. J., Witt, M. D., Bhasin, S., Budoff, M. J., Post, W. S., & Brown, T. T. (2024). Transgender Women With Suppressed Testosterone Display Lower Burden of Coronary Disease Than Matched Cisgender Men. Journal of the Endocrine Society, 8(8). https://doi.org/10.1210/jendso/bvae120

Vancouver

Lake JE, Feng H, Hyatt AN, Miao H, Debroy P, Funderburg N, et al. Transgender Women With Suppressed Testosterone Display Lower Burden of Coronary Disease Than Matched Cisgender Men. Journal of the Endocrine Society. 2024;8(8). doi:10.1210/jendso/bvae120

BibTeX
@article{Lake2024,
  author = {Lake, Jordan E and Feng, Han and Hyatt, Ana N and Miao, Hongyu and Debroy, Paula and Funderburg, Nicholas and Ailstock, Kate and Dobs, Adrian and Haberlen, Sabina and Magnani, Jared W and Margolick, Joseph B and McGowan, Kate and Palella, Frank J and Witt, Mallory D and Bhasin, Shalender and Budoff, Matthew J and Post, Wendy S and Brown, Todd T},
  title = {Transgender Women With Suppressed Testosterone Display Lower Burden of Coronary Disease Than Matched Cisgender Men},
  journal = {Journal of the Endocrine Society},
  year = {2024},
  volume = {8},
  number = {8},
  doi = {10.1210/jendso/bvae120}
}
Kostenlos starten →